chrX-38367361-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000531.6(OTC):c.148G>A(p.Gly50Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000242 in 1,197,395 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000025 ( 0 hom. 8 hem. )
Consequence
OTC
NM_000531.6 missense
NM_000531.6 missense
Scores
2
8
7
Clinical Significance
Conservation
PhyloP100: 3.70
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.24352771).
BS2
High Hemizygotes in GnomAdExome4 at 8 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.148G>A | p.Gly50Arg | missense_variant | 2/10 | ENST00000039007.5 | NP_000522.3 | |
OTC | NM_001407092.1 | c.148G>A | p.Gly50Arg | missense_variant | 4/12 | NP_001394021.1 | ||
OTC | XM_017029556.2 | c.148G>A | p.Gly50Arg | missense_variant | 2/9 | XP_016885045.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTC | ENST00000039007.5 | c.148G>A | p.Gly50Arg | missense_variant | 2/10 | 1 | NM_000531.6 | ENSP00000039007.4 | ||
ENSG00000250349 | ENST00000465127.1 | c.172-298760G>A | intron_variant | 5 | ENSP00000417050.1 | |||||
OTC | ENST00000488812.1 | n.240G>A | non_coding_transcript_exon_variant | 2/6 | 5 | |||||
OTC | ENST00000643344.1 | n.148G>A | non_coding_transcript_exon_variant | 2/11 | ENSP00000496606.1 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111170Hom.: 0 Cov.: 22 AF XY: 0.0000300 AC XY: 1AN XY: 33376
GnomAD3 genomes
AF:
AC:
2
AN:
111170
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33376
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000491 AC: 9AN: 183116Hom.: 0 AF XY: 0.0000590 AC XY: 4AN XY: 67764
GnomAD3 exomes
AF:
AC:
9
AN:
183116
Hom.:
AF XY:
AC XY:
4
AN XY:
67764
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000249 AC: 27AN: 1086172Hom.: 0 Cov.: 27 AF XY: 0.0000227 AC XY: 8AN XY: 352170
GnomAD4 exome
AF:
AC:
27
AN:
1086172
Hom.:
Cov.:
27
AF XY:
AC XY:
8
AN XY:
352170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111223Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33439
GnomAD4 genome
AF:
AC:
2
AN:
111223
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33439
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
8
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Aug 09, 2019 | - - |
not provided Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | GenMed Metabolism Lab | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Loss of ubiquitination at K46 (P = 0.0429);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at